‘Paradigm shift’ in type 1 diabetes shows new drugs which could delay disease’s emergence Scientists may have been looking in the wrong place for a cure to type 1 diabetes after a new study claims to have found “a paradigm shift” in treatment.
Researchers have found the disease could be kept at bay in animals by clearing out defective insulin-producing cells.
Drug development has previously been focused on preserving these “beta cells” by preventing the immune system wiping them out, but US researchers say their findings turn this on its head. The Indpendent
See also:
Researchers have found the disease could be kept at bay in animals by clearing out defective insulin-producing cells.
Drug development has previously been focused on preserving these “beta cells” by preventing the immune system wiping them out, but US researchers say their findings turn this on its head. The Indpendent
See also:
- Targeted Elimination of Senescent Beta Cells Prevents Type 1 Diabetes (abstract) Cell Metabolism
No comments:
Post a Comment